STAT

Head of IBM Watson Health leaving post after company stumbles, growing criticism

Head of IBM Watson Health leaving post after company stumbles, growing criticism
Deborah DiSanzo served as the head of IBM's health division for three years.

After a rocky three years as head of IBM’s health division, Deborah DiSanzo is leaving her role.

A company spokesman told STAT that DiSanzo will no longer lead IBM Watson Health, the Cambridge-based division that has pitched the company’s famed artificial intelligence capabilities as solutions for a myriad

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks